[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Clinical Trials for Newly Diagnosed Myeloma Patients with John Rosengard

Clinical Trials for Newly Diagnosed Myeloma Patients with John Rosengard image

Clinical Trials for Newly Diagnosed Myeloma Patients with John Rosengard

Webinar
event May 26, 2022 / 07:00PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Clinical Trials are often considered for those at the end of their treatment who are in need of novel therapies. But is there a need for newly diagnosed patients to participate in clinical trials as well? Come hear the patient experience of myeloma patient, John Rosengard, who participated in the GRIFFIN trial when he was newly diagnosed.

Schedule & Agenda

Event panelist Audrey Burton-Bethkee
07:00 PM
Introduction
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. John Rosengard.
Event panelist John Rosengard
07:05 PM
Presentation
John Rosengard
Josh talks about participating in the GRIFFIN trial when he was newly diagnosed.
Event panelist Audience
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist John Rosengard
John Rosengard

John Rosengard is a multiple myeloma survivor from Oakland, California. He is a patient of Dr. Nina Shah at UCSF and participated in the GRIFFIN clinical trial from 2017-2021. He works in the environmental cleanup field and worked full time through treatment…except for the weeks after the 2018 stem cell transplant! He is a MyelomaTree coach and active supporter of his fellow patients.

Read Bio
The panelist Todd Foster
Todd Foster

Todd Foster is the Director of Digital Patient Engagement at HealthTree. He worked at MD Anderson Cancer Center for 12 years before helping myeloma patient, Jenny Ahlstrom, start up HealthTree Cure Hub. He specializes in patient experience, helping patients understand their options, and becoming decision makers with their care teams. Prior experience includes IT development projects at Intermountain HealthCare and UnitedHealthcare. Todd has a passion for using technology that can help patients have a better life, and along the way, help to further research for a cure.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Amgen logo
Sanofi logo
Adaptive logo
Pfizer logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.